Digital algorithm ePOCT+ successfully reduces antibiotic prescriptions in children, combating antimicrobial resistance

Study demonstrates how the ePOCT+ digital algorithm effectively guides healthcare providers in prescribing antibiotics for children, significantly reducing unnecessary antibiotic use and addressing antimicrobial resistance without compromising patient outcomes.

EMA approves Dupixent for young EoE patients

The EMA’s decision marks an expansion from the initial EU approval for EoE treatment in adolescents and adults. Credit: Orawan Pattarawimonchai/Shutterstock. The European Medicines Agency

November 7, 2024

Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference – Biotech Investments

Rancho Cucamonga, 04/01/2024 / 03:00, PST/PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc. RANCHO CUCAMONGA, CA / ACCESSWIRE / April 1, 2024 / Amphastar Pharmaceuticals,

April 2, 2024

The Role of DLT in Cross-Border Healthcare Data Sharing

Michael Dersham Founder & CEO, Apierion The inability to access appropriate care close to home has been a long-standing cause of health inequity in the

December 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.